retatrutide ada 2025 results More data on dropped today at the conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide Month 1 Results: Typical

Weight Management Support Powered by Peptide GLP-1 Support for Satiety &amp

Food intake was standardized, and blood samples were obtained every third hour

Paired data where patients completed the questionnaire in both years were available in 31.4% (522/1665 [95% CIs 29.2-33.6%])

But sooner or later, almost everyone on one asks the same question

Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among some dermatologists who may also prescribe a teratogenic drug like isotretinoin for acne

Some of the many news media personalities who have publicly talked about using GLP-1 medications for weight loss include Oprah Winfrey and Andy Cohen.